New Predictions on COVID-19 Vaccines and Herd Immunity
How COVID-19 case counts and vaccines may get us back to normalcy by June.
Social distancing may be necessary for two years or more. Here's where remote care comes into play.
Specialty drugs represent an opportunity to better serve patients, but also pose risks.
The recent rise of custom-made drugs is already redefining the state of regulation, society, and the economy.
In our rearview mirror is a ten-year stretch of experimentation. What looms ahead is the rewriting of healthcare's rules.
Whoever's closest to the consumer will be the gatekeeper of the industry.
Three percent of consumers drive 70 percent of pharmacy spend. Pharmacy is ripe for change.
It's time to get comfortable with being uncomfortable.
How measurement and monitoring will wake physicians up to their dangerous, unnecessary, (and unintentional) prescribing habits.
There's big buzz around consumer behavior driving outcomes. But clinical data doesn't yet align with behavioral data.
